CDH
NWBO
Charles D. Hyman’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-249,625
| Closed | -$87K | – | 154 |
|
|
2016
Q4 | $87K | Hold |
249,625
| – | – | 0.01% | 137 |
|
|
2016
Q3 | $135K | Buy |
249,625
+204,250
| +450% | +$110K | 0.02% | 135 |
|
|
2016
Q2 | $26K | Hold |
45,375
| – | – | ﹤0.01% | 141 |
|
|
2016
Q1 | $66K | Hold |
45,375
| – | – | 0.01% | 138 |
|
|
2015
Q4 | $145K | Hold |
45,375
| – | – | 0.02% | 136 |
|
|
2015
Q3 | $284K | Buy |
45,375
+12,000
| +36% | +$75.1K | 0.05% | 123 |
|
|
2015
Q2 | $331K | Sell |
33,375
-10,000
| -23% | -$99.2K | 0.05% | 123 |
|
|
2015
Q1 | $320K | Buy |
43,375
+2,000
| +5% | +$14.8K | 0.05% | 124 |
|
|
2014
Q4 | $221K | Hold |
41,375
| – | – | 0.04% | 129 |
|
|
2014
Q3 | $208K | Hold |
41,375
| – | – | 0.03% | 136 |
|
|
2014
Q2 | $278K | Buy |
41,375
+4,000
| +11% | +$26.9K | 0.05% | 125 |
|
|
2014
Q1 | $271K | Sell |
37,375
-2,000
| -5% | -$14.5K | 0.05% | 120 |
|
|
2013
Q4 | $148K | Buy |
39,375
+19,000
| +93% | +$71.4K | 0.03% | 134 |
|
|
2013
Q3 | $68K | Hold |
20,375
| – | – | 0.01% | 139 |
|
|
2013
Q2 | $68K | Buy |
+20,375
| New | +$68K | 0.01% | 135 |
|